09/09/2025 3:42 PM | Nautilus Biotechnology (Issuer) Patel Sujal M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2025 5:34 PM | Murphy Matthew B. (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:36 PM | Akinsanya Karen (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:37 PM | Nautilus Biotechnology (Issuer) NAZEM FARZAD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:37 PM | McIlwain Matthew S (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:37 PM | Nautilus Biotechnology (Issuer) Posard Matthew L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2025 3:37 PM | Epperly Melissa B, (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 3:34 PM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2025 4:12 PM | Mowry Anna (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2025 6:19 PM | Mallick Parag (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2025 3:30 PM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2025 3:44 PM | Nautilus Biotechnology (Issuer) Patel Sujal M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 3:52 PM | Nautilus Biotechnology (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2025 8:06 PM | Nautilus Biotechnology (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
01/31/2025 4:15 PM | Nautilus Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2024 4:21 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 3:28 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 3:28 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 3:31 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024 4:28 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024 10:38 AM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 3:25 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024 5:29 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 3:58 PM | Godwin Mary E. (Reporting) Nautilus Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |